Melanoma symptoms provide key warning signs that can help you find this disease early, when it is most treatable. Learn ...

A novel chimeric antigen receptor T-cell therapy may benefit patients with B-cell lymphomas who previously relapsed following ...

During a live event, Priyanka Pophali, MD, MBBS, discussed CAR T-cell therapy referrals, timing, and challenges in relapsed ...

New findings show that the stage of normal cell development at which B cells transform into leukemic cells impacts treatment ...

TOPLINE: In a large US cohort study, patients with primary cutaneous B-cell lymphoma (pCBCL) had significantly higher risks of developing hematologic and prostate cancers. METHODOLOGY: Researchers ...

About Phase 1/2a study During the first part of the Phase 1/2a study ( NCT04752826 ) the safety, tolerability, and potential signs of efficacy of BI-1808 as a single agent (Part A) and in combination ...

B-Cell Skin Lymphoma Cutaneous B-cell lymphoma (CBCL), also occurs when a mutation develops in the cell. The mutation instructs the cell to divide rapidly and allows it to live longer than it should.

If your doctor tells you that you have B-cell lymphoma, it means you have a cancer that forms in white blood cells called lymphocytes. Find out what causes it, the symptoms, and the reasons you ...

Explore diffuse large B-cell lymphoma — symptoms, causes, diagnosis, treatment options, and prevention. Learn about its types, risk factors, and prognosis.

Intravascular large B-cell lymphoma (IVLBCL) is a rare type of non-Hodgkin's lymphoma. Learn about symptoms, diagnosis, treatment, and outlook.